A collective of expert urologists, medical specialists, and experienced researchers working to change the way the world diagnoses and treats prostate disease
Prof. Hashim Ahmed (@LondonProstate1), consultant urological surgeon and Chief Investigator of TRANSFORM, said: “The extension of the study is a huge step forwards and we hope it will help to fill the current gaps in evidence and inform future decisions on national screening."
We're expanding research, widening treatment options and tackling inequalities in prostate cancer care.
✅ All eligible Black men will be invited to join a landmark screening trial.
✅ A targeted NHS screening programme will also be rolled out.
More: gov.uk/government/news/major…
More black men will be offered prostate cancer checks as part of the Transform trial.
Black men are known to be at increased risk of prostate cancer - double the risk of other men.
#prostatecancer
👏Great news from DHSC supporting PCa research & better evidence for Black men
🔬 PCa screening policy must be built on robust evidence.
📈Expanding TRANSFORM will help generate evidence for earlier, fairer and safer screening
gov.uk/government/news/major…@zubirahmed@DavidLammy
📣The £42M TRANSFORM study will get a £20M boost so that all eligible Black men are invited to join stage 2
📶Policies on healthcare for any group to be based on evidence
🇬🇧Govt also funding wider access to focal prostate therapy to ⬇️ harms of surgery & radiotherapy
We're expanding research, widening treatment options and tackling inequalities in prostate cancer care.
✅ All eligible Black men will be invited to join a landmark screening trial.
✅ A targeted NHS screening programme will also be rolled out.
More: gov.uk/government/news/major…
📣The £42M TRANSFORM study will get a £20M boost so that all eligible Black men are invited to join stage 2
📶Policies on healthcare for any group to be based on evidence
🇬🇧Govt also funding wider access to focal prostate therapy to ⬇️ harms of surgery & radiotherapy
TRANSFORM study extends prostate cancer screening to Black men in the UK
S&C's @LondonProstate1 welcomes the news that all eligible Black men in the UK will be offered prostate cancer screening as part of the landmark TRANSFORM study ⬇️
imperial.ac.uk/news/articles…
We're expanding research, widening treatment options and tackling inequalities in prostate cancer care.
✅ All eligible Black men will be invited to join a landmark screening trial.
✅ A targeted NHS screening programme will also be rolled out.
More: gov.uk/government/news/major…
Today we're stepping up the fight against prostate cancer.
Black men face a significantly higher risk of developing and dying from the disease.
That’s why we're taking action by ensuring all eligible Black men are invited to join a vital new trial. Early diagnosis saves lives✅
TRANSFORM study extends prostate cancer screening to Black men in the UK
S&C's @LondonProstate1 welcomes the news that all eligible Black men in the UK will be offered prostate cancer screening as part of the landmark TRANSFORM study ⬇️
imperial.ac.uk/news/articles…
BIG NEWS 📢
The Government has announced up to £18 million in additional funding for TRANSFORM - recognising the crucial role our trial is playing in shaping the future of #ProstateCancer screening.
➡️ Read more: bit.ly/4x9jOVE#MensHealth l #Screening
ALT Breaking news banner with the text: 'Government backs our groundbreaking TRANSFORM trial with an additional £18 million in funding.'
Great to speak to you Adam.
Focal therapy is an increasingly important field to rebalance the harms: benefit ratio in the debate around screening of prostate cancer
@FocalSociety@UkFocal@IP_London
Interesting to see that majority of urology consultants responding to this agreeing with National Screening Committee decision on not screening the general population for prostate but disagree with recommendations not to screen Black men and those with family history.
Delighted to have been awarded Best Poster at #AUA2026 presenting @IP_London#ATLANTA trial complete pathological response pilot data on behalf of the investigators. Full trial results due early 2027.
Further #AUA2026 highlights with the @IP_London team in a very sunny Washington DC:
- Presenting #AVIDITY in the Trial in Progress session
- Air conditioned IP
- IP melting
- Robotic candy floss!